Vendor, Washington, DC
Albert B. Sabin Vaccine Institute, Inc. (The)
UEI H5E8NU6N2HZ5, CAGE 5MPW2
3 awards and $356,898,734 obligated between January 10, 2024 and September 18, 2026, 67% under full and open competition, against 1.7 offers on average where reported. 5 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $356,898,734 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $356,898,734 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Full and Open Competition After Exclusion of Sources | 1 |
| Definitive Contract | 3 |
Hear when Albert B. Sabin Vaccine Institute, Inc. (The) wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Albert B. Sabin Vaccine Institute, Inc. (The) holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $1,593,246
- Soonest
- September 30, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Office of Assistant Secretary for Preparedness and Response, by dollars.
| Advanced Technology InternationalSummerville, SC | $2,764,576,471 |
| Amgen USA Inc.Thousand Oaks, CA | $345,705,117 |
| Start2 Group, Inc.Cambridge, MA | $227,139,021 |
| Siga Technologies, Inc.New York, NY | $177,835,284 |
| Shionogi Inc.Florham Park, NJ | $156,109,904 |
| Mapp Biopharmaceutical, Inc.San Diego, CA | $134,279,350 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA
Award noticeNAICS 541714Anywhere in the US75A50125R00006Awarded to Albert B. Sabin Vaccine Institute, Inc. (The) for $1,042,099,118
Posted May 75 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50126C00001Definitive Contract, May 5, 2026, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (Smart-Prep)NAICS 541714, PSC 6505 | $263,613,186 |
| 75A50123C00010Definitive Contract, May 16, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | The Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (Bulk Drug Substance (Bds) and Final Drug ProductNAICS 541714, PSC AN42 | $91,692,302 |
| 75A50119C00055Definitive Contract, January 10, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advance the Development of Monovalent Vaccines for Prevention of Marburg Virus (Marv) and Sudan Ebolavirus (Sudv) Disease.NAICS 541714, PSC AN73 | $1,593,246 |
- Places of performance
- District of Columbia
- Product and service codes
- 6505 Drugs and BiologicalsAN42 Health R&D Services; Health Care - Other; Applied ResearchAN73 N – Health R&D Services
- Transactions
- 20 across 3 awards